MarketCap
Facebook
X
TelegramAdamas Pharmaceuticals, Inc. Total Current Liabilities 2011-2026 | ADMS
Annual Total Current Liabilities Adamas Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 34.9 M | 26.9 M | 24.3 M | 16.6 M | 9.74 M | 11.8 M | 12.5 M | 4.22 M | 38.5 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 38.5 M | 4.22 M | 19.9 M |
Total Current Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ARCA biopharma
ABIO
|
13 M | - | 1052.0 % | $ 415 M |  USA |
 |
Albireo Pharma
ALBO
|
45.3 M | - | -0.23 % | $ 916 M | USA |
 |
Aileron Therapeutics
ALRN
|
5.75 M | - | 10.36 % | $ 9.8 M | USA |
 |
I-Mab
IMAB
|
576 M | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | USA |
 |
Aptinyx
APTX
|
6.29 M | - | -39.0 % | $ 4.57 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | USA |
 |
MediWound Ltd.
MDWD
|
8.27 M | $ 17.08 | 2.83 % | $ 465 M |  Israel |
 |
Amphastar Pharmaceuticals
AMPH
|
158 M | $ 19.7 | 2.44 % | $ 921 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
25.2 M | - | - | $ 26.5 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
7.54 M | - | - | $ 7.46 M | Israel |
 |
AgeX Therapeutics
AGE
|
5.91 M | - | -10.17 % | $ 12.2 K | USA |
 |
Acorda Therapeutics
ACOR
|
228 M | - | -24.86 % | $ 820 K | USA |
 |
Atreca
BCEL
|
16.3 M | - | -11.76 % | $ 5.79 M | USA |
 |
Acasti Pharma
ACST
|
1.93 M | - | 4.01 % | $ 150 M |  Canada |
 |
BeiGene, Ltd.
BGNE
|
1.83 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Mirum Pharmaceuticals
MIRM
|
206 M | $ 90.9 | 3.44 % | $ 4.56 B | USA |
 |
bluebird bio
BLUE
|
200 M | - | - | $ 546 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - |  Russia |
 |
Cara Therapeutics
CARA
|
25.6 M | - | -3.03 % | $ 260 M | USA |
 |
Adverum Biotechnologies
ADVM
|
22.9 M | - | - | $ 86.2 M | USA |
 |
Acer Therapeutics
ACER
|
19 M | - | 2.71 % | $ 14 M | USA |
 |
Advaxis
ADXS
|
25 M | - | -9.65 % | $ 45.9 M | USA |
 |
MediciNova
MNOV
|
3.8 M | $ 1.44 | -0.68 % | $ 70.7 M | USA |
 |
Avenue Therapeutics
ATXI
|
816 K | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
60.7 M | $ 1.36 | 3.03 % | $ 347 M |  Britain |
 |
CytomX Therapeutics
CTMX
|
46.6 M | $ 4.41 | 3.98 % | $ 608 M | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
6.27 M | - | -5.98 % | $ 34.1 M | USA |
 |
ChemoCentryx
CCXI
|
63 M | - | - | $ 3.74 B | USA |
 |
Merck & Co.
MRK
|
28.3 B | $ 118.9 | 2.17 % | $ 297 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
78.6 M | - | - | $ 2.02 B | USA |
 |
BioDelivery Sciences International
BDSI
|
82.4 M | - | -4.8 % | $ 255 M | USA |
 |
Enochian Biosciences
ENOB
|
29.2 M | - | - | $ 40.5 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
58.7 M | - | - | $ 1.01 B | USA |
 |
Bellerophon Therapeutics
BLPH
|
5.4 M | - | -74.18 % | $ 955 K | USA |
 |
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | USA |
 |
Neurocrine Biosciences
NBIX
|
743 M | $ 131.82 | 3.1 % | $ 13.1 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
6.01 M | $ 4.56 | 5.68 % | $ 874 M | Canada |
 |
Homology Medicines
FIXX
|
11.3 M | - | 0.77 % | $ 53.4 M | USA |
 |
Akouos
AKUS
|
16.8 M | - | 0.23 % | $ 488 M | USA |
 |
AIkido Pharma
AIKI
|
3.78 M | - | 1.93 % | $ 17.4 M | USA |
 |
Allakos
ALLK
|
36.6 M | - | - | $ 28.6 M | USA |